+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antihistamine Drugs Market - Global Forecast 2026-2032- Product Image
Antihistamine Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Antihistamine Drugs Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015086
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antihistamine Drugs Market is projected to reach USD 2.11 Billion in 2026. It is expected to continue growing at a CAGR of 8.75%, reaching USD 3.52 Billion by 2032.

Antihistamine Drugs: Executive Overview

Antihistamine drugs are used primarily to relieve symptoms associated with allergic rhinitis, urticaria, conjunctivitis, and related histamine-mediated conditions. The category includes older sedating agents and newer, generally less-sedating options, with treatment selection shaped by symptom profile, patient age, comorbidities, duration of use, and local prescribing and dispensing practices. Demand is influenced by seasonal allergies, indoor and outdoor exposures, diagnostic awareness, self-care behavior, and access to primary and specialist care.

How Allergy Care Is Shifting

The landscape is moving toward more individualized symptom management, with greater attention to sedation, anticholinergic effects, drug interactions, and suitability for children and older adults. Consumers increasingly seek convenient oral, nasal, and ophthalmic formats, while clinicians are distinguishing between rapid symptom relief and longer-term control strategies. Digital health information, pharmacy-led counseling, and improved awareness of allergic conditions are also influencing product selection and adherence.

Artificial Intelligence and Antihistamine Care

Artificial intelligence is beginning to affect antihistamine care through symptom-triage tools, medication-information services, demand planning, pharmacovigilance support, and analysis of real-world treatment patterns. These applications may help identify potential adverse-event signals, improve patient education, and support more consistent recommendations. However, reliable deployment requires validated clinical data, transparent decision logic, privacy safeguards, and human oversight, particularly when symptoms could reflect asthma, infection, anaphylaxis, or another condition requiring urgent evaluation.

Regional Patterns in Allergy Treatment

North America combines strong consumer access with substantial use of nonprescription allergy medicines and growing emphasis on safe self-selection. Latin America reflects varied healthcare access, regulatory environments, and pharmacy-centered purchasing patterns. Europe is shaped by harmonized regulatory principles alongside national reimbursement and prescribing differences. The Middle East faces pronounced seasonal and environmental exposure considerations in some locations, while access and clinical capacity vary across markets. Africa presents diverse allergy burdens, supply constraints, and uneven diagnostic coverage. Asia-Pacific combines dense urban exposure, changing pollution patterns, expanding healthcare access, and wide variation in regulatory and consumer practices.

Group-Level Dynamics Across Major Blocs

ASEAN markets differ considerably in healthcare infrastructure, climate-related exposure, regulatory implementation, and reliance on community pharmacies, making localized education and distribution important. BRICS members span diverse disease patterns, income levels, and public-private care systems, requiring differentiated access and safety strategies. The European Union benefits from shared regulatory foundations but retains national differences in reimbursement and clinical practice. G7 settings generally emphasize evidence-based use, medication safety, and mature pharmacy channels. GCC countries often combine high urbanization and healthcare investment with varied expatriate and local population needs. NATO members represent a broad set of healthcare systems in which allergy care priorities and medicine-access arrangements remain nationally determined.

Country Insights Across Priority Markets

Australia and New Zealand-oriented care settings emphasize seasonal exposure, pharmacy guidance, and consumer safety. Brazil and Mexico reflect large, diverse populations with differences in healthcare access and the role of retail pharmacies. Canada and the United States have extensive self-care channels alongside clinical management for persistent or complex symptoms. China and India combine expanding healthcare access with substantial regional and urban-rural variation. Japan and South Korea place strong value on convenience, product quality, and seasonal symptom management. France, Germany, Italy, Spain, and the United Kingdom operate within well-developed healthcare and pharmacy environments, while reimbursement, prescribing norms, and nonprescription availability differ. Russia’s access and treatment patterns are shaped by its national healthcare structure, regulatory context, and geographic breadth.

Priorities for Industry Leaders

Leaders should prioritize clear differentiation based on symptom relief, duration of action, sedation profile, formulation, and patient suitability rather than relying on broad category messaging. Strengthening pharmacist and clinician education can improve appropriate selection and referral for severe or persistent symptoms. Organizations should invest in robust safety monitoring, responsible digital tools, multilingual patient information, and supply resilience across diverse channels. Regional strategies should account for regulatory requirements, seasonal demand, affordability, local care pathways, and the appropriate boundary between self-medication and professional assessment.

Research Methodology for the Executive Summary

This executive summary uses the defined antihistamine-drug category and synthesizes established, non-quantitative industry considerations across the requested regions, groups, and countries. The assessment framework considers therapeutic use, formulation, patient safety, distribution, regulation, healthcare access, consumer behavior, environmental exposure, and technology adoption. No market estimates, market shares, forecasts, or company-specific claims are included. Country and bloc observations are presented as contextual comparisons rather than as measures of commercial performance.

Conclusion: Building Safer, More Responsive Allergy Care

Antihistamine drugs remain an important component of allergy symptom management, but the category is evolving toward greater personalization, convenience, and safety awareness. Regional and country differences in exposure, healthcare access, regulation, and purchasing behavior make a uniform strategy unsuitable. The strongest long-term approach combines evidence-based product positioning, responsible self-care support, effective professional guidance, dependable supply, and carefully governed use of artificial intelligence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antihistamine Drugs Market, by Drug Type
7.1. Introduction
7.2. H1 Antihistamines
7.2.1. First Generation Antihistamines
7.2.1.1. Chlorpheniramine
7.2.1.2. Diphenhydramine
7.2.1.3. Hydroxyzine
7.2.2. Second Generation Antihistamines
7.2.2.1. Cetirizine
7.2.2.2. Desloratadine
7.2.2.3. Fexofenadine
7.2.2.4. Loratadine
7.3. H2 Antihistamines
7.3.1. Cimetidine
7.3.2. Famotidine
7.3.3. Nizatidine
7.3.4. Ranitidine
7.4. H3 Antihistamines
8. Antihistamine Drugs Market, by Administration Route
8.1. Introduction
8.2. Nasal
8.2.1. Nasal sprays
8.2.2. Nebulizers
8.3. Oral
8.3.1. Capsules
8.3.2. Syrups & Liquids
8.3.3. Tablets
8.4. Parenteral
8.4.1. Intramuscular (IM)
8.4.2. Intravenous (IV)
8.5. Topical
9. Antihistamine Drugs Market, by Dosage Form
9.1. Introduction
9.2. Liquid
9.3. Semi Solid
9.4. Solid
10. Antihistamine Drugs Market, by Indication
10.1. Introduction
10.2. Allergic Conjunctivitis
10.3. Allergic Rhinitis
10.3.1. Perennial Allergic Rhinitis
10.3.2. Seasonal Allergic Rhinitis
10.4. Anaphylaxis Adjunctive Therapy
10.5. Cough & Cold
10.6. Gastroesophageal Reflux Disease And Peptic Ulcer
10.7. Insomnia
10.8. Motion Sickness & Vertigo
10.9. Nausea & Vomiting
10.10. Pruritus & Dermatoses
10.10.1. Atopic Dermatitis Pruritus
10.10.2. Contact Dermatitis Pruritus
10.11. Urticaria
10.11.1. Acute Urticaria
10.11.2. Chronic Spontaneous Urticaria
11. Antihistamine Drugs Market, by Prescription Status
11.1. Introduction
11.2. Over-The-Counter
11.3. Prescription-Only
12. Antihistamine Drugs Market, by Application
12.1. Introduction
12.2. Acute Symptomatic Relief
12.3. Chronic Allergy Management
12.4. Preventive / Prophylactic Use
13. Antihistamine Drugs Market, by Patient Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Antihistamine Drugs Market, by Sales Channel
14.1. Introduction
14.2. Offline
14.3. Online
15. Antihistamine Drugs Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. Europe
15.4. North America
15.5. Africa
15.6. Latin America
15.7. Middle East
16. Antihistamine Drugs Market, by Group
16.1. Introduction
16.2. NATO
16.3. G7
16.4. European Union
16.5. BRICS
16.6. ASEAN
16.7. GCC
17. Antihistamine Drugs Market, by Country
17.1. Introduction
17.2. United States
17.3. China
17.4. Germany
17.5. Japan
17.6. India
17.7. United Kingdom
17.8. France
17.9. Australia
17.10. Italy
17.11. Canada
17.12. South Korea
17.13. Russia
17.14. Brazil
17.15. Mexico
17.16. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Alcon Vision LLC
19.3. Almirall, S.A.
19.4. AstraZeneca PLC
19.5. Aurobindo Pharma Limited
19.6. Bayer AG
19.7. Boehringer Ingelheim International GmbH
19.8. Cipla Limited
19.9. Dr.Reddy’s Laboratories Ltd.
19.10. GlaxoSmithKline plc
19.11. GLENMARK PHARMACEUTICALS LTD
19.12. Hikma Pharmaceuticals PLC
19.13. Kenvue Inc.
19.14. Lunan Pharmaceutical Group Corporation
19.15. Lupin Limited
19.16. Merck & Co., Inc.
19.17. Novartis AG
19.18. Perrigo Company plc
19.19. Pfizer Inc.
19.20. Sandoz Group AG
19.21. Sanofi S.A.
19.22. Shanghai Pharmaceuticals Holding Co., Ltd.
19.23. Sun Pharmaceutical Industries Limited
19.24. Teva Pharmaceutical Industries Ltd.
19.25. Torrent Pharmaceuticals Limited
19.26. UCB S.A.
19.27. Viatris Inc.
19.28. Yangtze River Pharmaceutical Group
19.29. Zenomed Healthcare Private Limited
19.30. Zydus Group.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Antihistamine Drugs Market, Years Considered for the Study
FIGURE 2. Global Antihistamine Drugs Market, Research Design
FIGURE 3. Global Antihistamine Drugs Market, Research Framework
FIGURE 4. Global Antihistamine Drugs Market, Data Triangulation
FIGURE 5. Global Antihistamine Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Antihistamine Drugs Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Antihistamine Drugs Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Antihistamine Drugs Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 9. Global Antihistamine Drugs Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Antihistamine Drugs Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Antihistamine Drugs Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Antihistamine Drugs Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Antihistamine Drugs Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Antihistamine Drugs Market Size, by Prescription Status, 2025 vs 2032 (%)
FIGURE 15. Global Antihistamine Drugs Market Size, by Prescription Status, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Antihistamine Drugs Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Antihistamine Drugs Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Antihistamine Drugs Market Size, by Patient Group, 2025 vs 2032 (%)
FIGURE 19. Global Antihistamine Drugs Market Size, by Patient Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Antihistamine Drugs Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 21. Global Antihistamine Drugs Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Antihistamine Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Antihistamine Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Antihistamine Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Antihistamine Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Antihistamine Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Antihistamine Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Antihistamine Drugs Market Segmentation & Coverage
TABLE 2. Global Antihistamine Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global H1 Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global H1 Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global H1 Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global First Generation Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global First Generation Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global First Generation Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chlorpheniramine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chlorpheniramine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chlorpheniramine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Diphenhydramine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Diphenhydramine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Diphenhydramine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Hydroxyzine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Hydroxyzine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Hydroxyzine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Second Generation Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Second Generation Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Second Generation Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Cetirizine Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Cetirizine Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Cetirizine Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Desloratadine Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Desloratadine Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Desloratadine Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Fexofenadine Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Fexofenadine Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Fexofenadine Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Loratadine Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Loratadine Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Loratadine Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global H2 Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global H2 Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global H2 Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Cimetidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cimetidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cimetidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Famotidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Famotidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Famotidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Nizatidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Nizatidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Nizatidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Ranitidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Ranitidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Ranitidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global H3 Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global H3 Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global H3 Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 53. Global Nasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Nasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Nasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Nasal sprays Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Nasal sprays Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Nasal sprays Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Nebulizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Nebulizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Nebulizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Syrups & Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Syrups & Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Syrups & Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Intramuscular (IM) Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Intramuscular (IM) Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Intramuscular (IM) Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Intravenous (IV) Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Intravenous (IV) Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Intravenous (IV) Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 87. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Semi Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Semi Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Semi Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 97. Global Allergic Conjunctivitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Allergic Conjunctivitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Allergic Conjunctivitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Perennial Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Perennial Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Perennial Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Seasonal Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Seasonal Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Seasonal Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Anaphylaxis Adjunctive Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Anaphylaxis Adjunctive Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Anaphylaxis Adjunctive Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Cough & Cold Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Cough & Cold Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Cough & Cold Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Gastroesophageal Reflux Disease And Peptic Ulcer Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Gastroesophageal Reflux Disease And Peptic Ulcer Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Gastroesophageal Reflux Disease And Peptic Ulcer Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Insomnia Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Insomnia Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Insomnia Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Motion Sickness & Vertigo Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Motion Sickness & Vertigo Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Motion Sickness & Vertigo Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Nausea & Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Nausea & Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Nausea & Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Pruritus & Dermatoses Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Pruritus & Dermatoses Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Pruritus & Dermatoses Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Atopic Dermatitis Pruritus Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Atopic Dermatitis Pruritus Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Atopic Dermatitis Pruritus Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Contact Dermatitis Pruritus Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Contact Dermatitis Pruritus Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Contact Dermatitis Pruritus Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Urticaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Urticaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Urticaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Acute Urticaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Acute Urticaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Acute Urticaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Chronic Spontaneous Urticaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Chronic Spontaneous Urticaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Chronic Spontaneous Urticaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 146. Global Over-The-Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Over-The-Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Over-The-Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Prescription-Only Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Prescription-Only Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Prescription-Only Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Global Acute Symptomatic Relief Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Acute Symptomatic Relief Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Acute Symptomatic Relief Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Chronic Allergy Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Chronic Allergy Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Chronic Allergy Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Preventive / Prophylactic Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Preventive / Prophylactic Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Preventive / Prophylactic Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 163. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 173. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 185. Asia-Pacific Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 199. Europe Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Europe Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 201. Europe Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 202. Europe Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 203. Europe Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 204. Europe Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 205. Europe Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 206. Europe Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 207. Europe Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 208. Europe Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 209. Europe Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 210. Europe Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 211. Europe Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 212. Europe Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 213. Europe Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 214. Europe Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 215. Europe Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Europe Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 217. Europe Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 218. North America Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. North America Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 220. North America Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 221. North America Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 222. North America Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 223. North America Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 224. North America Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 225. North America Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 226. North America Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 227. North America Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 228. North America Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 229. North America Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 230. North America Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 231. North America Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 232. North America Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 233. North America Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 234. North America Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. North America Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 236. North America Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 237. Africa Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Africa Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 239. Africa Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 240. Africa Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 241. Africa Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 242. Africa Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 243. Africa Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 244. Africa Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 245. Africa Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 246. Africa Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 247. Africa Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 248. Africa Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 249. Africa Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 250. Africa Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 251. Africa Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 252. Africa Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 253. Africa Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Africa Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 255. Africa Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 256. Latin America Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 257. Latin America Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 258. Latin America Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 259. Latin America Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 260. Latin America Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 261. Latin America Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 262. Latin America Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 263. Latin America Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 264. Latin America Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 265. Latin America Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 266. Latin America Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 267. Latin America Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 268. Latin America Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 269. Latin America Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 270. Latin America Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 271. Latin America Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 272. Latin America Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Latin America Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 274. Latin America Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 275. Middle East Antihistamine Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 276. Middle East Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 277. Middle East Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 278. Middle East Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 279. Middle East Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 280. Middle East Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 281. Middle East Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 282. Middle East Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 283. Middle East Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 284. Middle East Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 285. Middle East Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 286. Middle East Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. Middle East Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 288. Middle East Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 289. Middle East Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 290. Middle East Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 291. Middle East Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Middle East Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 293. Middle East Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 294. Global Antihistamine Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 295. NATO Antihistamine Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 296. NATO Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 297. NATO Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 298. NATO Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 299. NATO Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 300. NATO Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 301. NATO Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 302. NATO Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 303. NATO Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 304. NATO Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 305. NATO Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 306. NATO Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 307. NATO Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 308. NATO Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 309. NATO Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 310. NATO Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 311. NATO Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. NATO Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 313. NATO Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 314. G7 Antihistamine Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 315. G7 Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 316. G7 Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 317. G7 Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 318. G7 Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 319. G7 Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 320. G7 Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 321. G7 Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 322. G7 Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 323. G7 Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 324. G7 Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 325. G7 Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 326. G7 Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 327. G7 Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 328. G7 Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 329. G7 Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 330. G7 Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. G7 Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 332. G7 Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 333. European Union Antihistamine Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. European Union Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 335. European Union Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 336. European Union Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 337. European Union Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 338. European Union Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 339. European Union Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 340. European Union Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 341. European Union Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 342. European Union Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 343. European Union Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 344. European Union Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 345. European Union Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 346. European Union Antihistamine Drugs Market Size, by Pruritus & Dermatoses, 2017-2032 (USD Million)
TABLE 347. European Union Antihistamine Drugs Market Size, by Urticaria, 2017-2032 (USD Million)
TABLE 348. European Union Antihistamine Drugs Market Size, by Prescription Status, 2017-2032 (USD Million)
TABLE 349. European Union Antihistamine Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. European Union Antihistamine Drugs Market Size, by Patient Group, 2017-2032 (USD Million)
TABLE 351. European Union Antihistamine Drugs Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 352. BRICS Antihistamine Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 353. BRICS Antihistamine Drugs Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 354. BRICS Antihistamine Drugs Market Size, by H1 Antihistamines, 2017-2032 (USD Million)
TABLE 355. BRICS Antihistamine Drugs Market Size, by First Generation Antihistamines, 2017-2032 (USD Million)
TABLE 356. BRICS Antihistamine Drugs Market Size, by Second Generation Antihistamines, 2017-2032 (USD Million)
TABLE 357. BRICS Antihistamine Drugs Market Size, by H2 Antihistamines, 2017-2032 (USD Million)
TABLE 358. BRICS Antihistamine Drugs Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 359. BRICS Antihistamine Drugs Market Size, by Nasal, 2017-2032 (USD Million)
TABLE 360. BRICS Antihistamine Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 361. BRICS Antihistamine Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 362. BRICS Antihistamine Drugs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 363. BRICS Antihistamine Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 364. BRICS Antihistamine Drugs Market Size, by Allergic Rhinitis, 2017-2032 (USD Million)
TABLE 365. BRICS Antihistam

Companies Mentioned

  • Abbott Laboratories
  • Alcon Vision LLC
  • Almirall, S.A.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • Dr.Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • GLENMARK PHARMACEUTICALS LTD
  • Hikma Pharmaceuticals PLC
  • Kenvue Inc.
  • Lunan Pharmaceutical Group Corporation
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sandoz Group AG
  • Sanofi S.A.
  • Shanghai Pharmaceuticals Holding Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Limited
  • UCB S.A.
  • Viatris Inc.
  • Yangtze River Pharmaceutical Group
  • Zenomed Healthcare Private Limited
  • Zydus Group.

Related Topics

Related Reports

Antihistamine Nose Spray Market - Global Forecast 2026-2032 - Product Image

Antihistamine Nose Spray Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Antihistamine Market - Global Strategic Business Report - Product Image

Antihistamine Market - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Antihistamine Spray Market - Global Forecast 2026-2032 - Product Image

Antihistamine Spray Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Antihistamine Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Antihistamine Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Pet Allergy Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Antihistamines, Corticosteroids, Immunotherapy, Monoclonal antibodies, Microbiome-modulating agents, Other Drug Classes), Pet Type, Route of Administration, Distribution Channel - Product Image

Pet Allergy Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Antihistamines, Corticosteroids, Immunotherapy, Monoclonal antibodies, Microbiome-modulating agents, Other Drug Classes), Pet Type, Route of Administration, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.